Agilent Technologies’ (A) “Hold (C)” Rating Reiterated at Weiss Ratings

Weiss Ratings restated their hold (c) rating on shares of Agilent Technologies (NYSE:A) in a research note published on Friday,Weiss Ratings reports.

A number of other equities analysts have also recently issued reports on the stock. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Wells Fargo & Company increased their price objective on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, September 15th. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective for the company. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Price Performance

NYSE A opened at $148.03 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The company has a fifty day simple moving average of $130.39 and a 200 day simple moving average of $119.43. The company has a market cap of $41.97 billion, a P/E ratio of 34.75, a P/E/G ratio of 4.83 and a beta of 1.26. Agilent Technologies has a 1 year low of $96.43 and a 1 year high of $153.84.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the firm earned $1.32 EPS. The business’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were given a dividend of $0.248 per share. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Institutional Investors Weigh In On Agilent Technologies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Capital A Wealth Management LLC increased its position in Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares in the last quarter. Davis Capital Management bought a new position in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Stone House Investment Management LLC bought a new position in shares of Agilent Technologies in the 1st quarter valued at about $30,000. Ransom Advisory Ltd bought a new position in shares of Agilent Technologies in the 1st quarter valued at about $32,000. Finally, Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies in the 2nd quarter valued at about $33,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.